{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:02:31Z","timestamp":1790402551745,"version":"4.1.0"},"reference-count":128,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2587,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1002\/humu.20748","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T20:46:26Z","timestamp":1210365986000},"page":"992-1006","source":"Crossref","is-referenced-by-count":316,"title":["The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders"],"prefix":"10.1155","volume":"29","author":[{"given":"Yoko","family":"Aoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Niihori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1002\/humu.20748-BIB1","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ajmg.a.31819","article-title":"Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome","volume":"143","author":"Al-Rahawan","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat Med"},{"key":"10.1002\/humu.20748-BIB4","doi-asserted-by":"crossref","first-page":"21353","DOI":"10.1074\/jbc.271.35.21353","article-title":"Insulin signaling in mice expressing reduced levels of Syp","volume":"271","author":"Arrandale","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.20748-BIB5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0092-8674(90)90115-U","article-title":"Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter","volume":"62","author":"Bailleul","year":"1990","journal-title":"Cell"},{"key":"10.1002\/humu.20748-BIB6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev.bi.56.070187.004023","article-title":"ras genes","volume":"56","author":"Barbacid","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1002\/humu.20748-BIB7","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1128\/MCB.23.14.4778-4787.2003","article-title":"Mek2 is dispensable for mouse growth and development","volume":"23","author":"Belanger","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.20748-BIB8","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","article-title":"Activating mutations of the noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia","volume":"64","author":"Bentires-Alj","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/humu.20748-BIB9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/gte.2006.10.186","article-title":"PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype","volume":"10","author":"Bertola","year":"2006","journal-title":"Genet Test"},{"key":"10.1002\/humu.20748-BIB10","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2005-0995","article-title":"PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome","volume":"90","author":"Binder","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/humu.20748-BIB11","first-page":"75","article-title":"DNA methylation affecting the transforming activity of the human Ha-ras oncogene","volume":"47","author":"Borrello","year":"1987","journal-title":"Cancer Res"},{"key":"10.1002\/humu.20748-BIB12","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB13","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"key":"10.1002\/humu.20748-BIB14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/302033a0","article-title":"Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue","volume":"302","author":"Capon","year":"1983","journal-title":"Nature"},{"key":"10.1002\/humu.20748-BIB15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1086\/504394","article-title":"Germline Missense Mutations Affecting KRAS Isoform B Are Associated with a Severe Noonan Syndrome Phenotype","volume":"79","author":"Carta","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20748-BIB16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI20476","article-title":"Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease","volume":"113","author":"Chan","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1002\/humu.20748-BIB17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0092-8674(89)90427-3","article-title":"Expression of the H-ras proto-oncogene is controlled by alternative splicing","volume":"58","author":"Cohen","year":"1989","journal-title":"Cell"},{"key":"10.1002\/humu.20748-BIB18","first-page":"397","article-title":"A new syndrome","volume":"74","author":"Costello","year":"1971","journal-title":"NZ Med J"},{"key":"10.1002\/humu.20748-BIB19","first-page":"114","article-title":"A new syndrome: mental subnormality and nasal papillomata","volume":"13","author":"Costello","year":"1977","journal-title":"Aust Paediatr J"},{"key":"10.1002\/humu.20748-BIB20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1002\/humu.20748-BIB21","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1073\/pnas.79.11.3637","article-title":"Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses","volume":"79","author":"Der","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.20748-BIB22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20748-BIB23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/humu.20748-BIB24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/MCB.21.5.1444-1452.2001","article-title":"Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development","volume":"21","author":"Esteban","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.20748-BIB25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.a.31078","article-title":"HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy","volume":"140","author":"Estep","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB26","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1073\/pnas.81.13.4008","article-title":"Analysis of the transforming potential of the human H-ras gene by random mutagenesis","volume":"81","author":"Fasano","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.20748-BIB27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/excr.1999.4668","article-title":"Shp-2 tyrosine phosphatase: signaling one cell or many","volume":"253","author":"Feng","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1002\/humu.20748-BIB28","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1210\/jc.2004-2559","article-title":"PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome","volume":"90","author":"Ferreira","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/humu.20748-BIB29","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1101\/gad.947701","article-title":"Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes","volume":"15","author":"Fisher","year":"2001","journal-title":"Genes Dev"},{"key":"10.1002\/humu.20748-BIB30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.20748-BIB31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","article-title":"Guilty as charged: B-RAF is a human oncogene","volume":"6","author":"Garnett","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1002\/humu.20748-BIB32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/BC.2005.025","article-title":"Oncogenic Ras in tumour progression and metastasis","volume":"386","author":"Giehl","year":"2005","journal-title":"Biol Chem"},{"key":"10.1002\/humu.20748-BIB33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/08035250510027264","article-title":"A new PTPN11 mutation in juvenile myelomonocytic leukaemia associated with Noonan syndrome","volume":"94","author":"Giovannini","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1002\/humu.20748-BIB34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0960-9822(99)80164-X","article-title":"Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta","volume":"9","author":"Giroux","year":"1999","journal-title":"Curr Biol"},{"key":"10.1002\/humu.20748-BIB35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.10241","article-title":"Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol","volume":"108","author":"Gripp","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.20748-BIB36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30065","article-title":"Tumor predisposition in Costello syndrome","volume":"137","author":"Gripp","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1002\/humu.20748-BIB37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.31047","article-title":"HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation","volume":"140","author":"Gripp","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB38","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/ajmg.a.31456","article-title":"Somatic mosaicism for an HRAS mutation causes Costello syndrome","volume":"140","author":"Gripp","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1535-6108(03)00191-0","article-title":"Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context","volume":"4","author":"Guerra","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1002\/humu.20748-BIB40","first-page":"5178","article-title":"Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein that trafficks to cytoplasm and nucleus","volume":"63","author":"Guil","year":"2003","journal-title":"Cancer Res"},{"key":"10.1002\/humu.20748-BIB41","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","article-title":"Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3\u2009K binding on Gab1","volume":"580","author":"Hanna","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1002\/humu.20748-BIB42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: an overview","volume":"117","author":"Hennekam","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1002\/humu.20748-BIB43","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1083\/jcb.151.7.1537","article-title":"Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration","volume":"151","author":"Heumann","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1002\/humu.20748-BIB44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.0022-202X.2004.23225.x","article-title":"Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions","volume":"123","author":"Hobbs","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1002\/humu.20748-BIB45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"key":"10.1002\/humu.20748-BIB46","first-page":"611","article-title":"The alternative H-ras protein p19 displays properties of a negative regulator of p21Ras","volume":"9","author":"Huang","year":"1997","journal-title":"Oncol Res"},{"key":"10.1002\/humu.20748-BIB47","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.270.39.23173","article-title":"Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice","volume":"270","author":"Hunter","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.20748-BIB48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-002-0803-6","article-title":"Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome","volume":"111","author":"Ion","year":"2002","journal-title":"Hum Genet"},{"key":"10.1002\/humu.20748-BIB49","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev"},{"key":"10.1002\/humu.20748-BIB50","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1101\/gad.11.19.2468","article-title":"K-ras is an essential gene in the mouse with partial functional overlap with N-ras","volume":"11","author":"Johnson","year":"1997","journal-title":"Genes Dev"},{"key":"10.1002\/humu.20748-BIB51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-3476(98)70284-7","article-title":"Costello syndrome: phenotype, natural history, differential diagnosis, and possible cause","volume":"133","author":"Johnson","year":"1998","journal-title":"J Pediatr"},{"key":"10.1002\/humu.20748-BIB52","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/35074129","article-title":"Somatic activation of the K-ras oncogene causes early onset lung cancer in mice","volume":"410","author":"Johnson","year":"2001","journal-title":"Nature"},{"key":"10.1002\/humu.20748-BIB53","first-page":"567","article-title":"Embryonal tumors from transgenic mouse zygotes carrying human activated c-Ha-ras genes","volume":"6","author":"Katsuki","year":"1989","journal-title":"Mol Biol Med"},{"key":"10.1002\/humu.20748-BIB54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.ejhg.5200911","article-title":"PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome","volume":"11","author":"Kavamura","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1002\/humu.20748-BIB55","doi-asserted-by":"crossref","first-page":"30984","DOI":"10.1074\/jbc.M504699200","article-title":"Diverse biochemical properties of Shp2 mutants","volume":"280","author":"Keilhack","year":"2005","journal-title":"Implications for disease phenotypes. J Biol Chem"},{"key":"10.1002\/humu.20748-BIB56","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1136\/jmg.2004.021451","article-title":"PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience","volume":"41","author":"Keren","year":"2004","journal-title":"J Med Genet"},{"key":"10.1002\/humu.20748-BIB57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmg.2005.040352","article-title":"Genotype-phenotype correlation in Costello syndrome; HRAS mutation analysis in 43 cases","volume":"43","author":"Kerr","year":"2006","journal-title":"J Med Genet"},{"key":"10.1002\/humu.20748-BIB58","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.onc.1201284","article-title":"K-ras is essential for the development of the mouse embryo","volume":"15","author":"Koera","year":"1997","journal-title":"Oncogene"},{"key":"10.1002\/humu.20748-BIB59","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.20748-BIB60","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1210\/jcem.87.8.8694","article-title":"PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome","volume":"87","author":"Kosaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/humu.20748-BIB61","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","article-title":"The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease","volume":"106","author":"Kratz","year":"2005","journal-title":"Blood"},{"key":"10.1002\/humu.20748-BIB62","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1523\/JNEUROSCI.2836-05.2005","article-title":"Modulation of presynaptic plasticity and learning by the H-ras\/extracellular signal-regulated kinase\/synapsin I signaling pathway","volume":"25","author":"Kushner","year":"2005","journal-title":"J Neurosci"},{"key":"10.1002\/humu.20748-BIB63","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.6356358","article-title":"Cellular oncogenes and multistep carcinogenesis","volume":"222","author":"Land","year":"1983","journal-title":"Science"},{"key":"10.1002\/humu.20748-BIB64","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmg.39.8.571","article-title":"PTPN11 mutations in LEOPARD syndrome","volume":"39","author":"Legius","year":"2002","journal-title":"J Med Genet"},{"key":"10.1002\/humu.20748-BIB65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/jc.2005-0983","article-title":"Noonan syndrome: relationships between genotype, growth, and growth factors","volume":"91","author":"Limal","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/humu.20748-BIB66","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.leu.2403492","article-title":"PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group","volume":"18","author":"Loh","year":"2004","journal-title":"Leukemia"},{"key":"10.1002\/humu.20748-BIB67","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"10.1002\/humu.20748-BIB68","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.leukres.2004.10.001","article-title":"Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"29","author":"Loh","year":"2005","journal-title":"Leuk Res"},{"key":"10.1002\/humu.20748-BIB69","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","article-title":"Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling","volume":"8","author":"Lu","year":"2001","journal-title":"Mol Cell"},{"key":"10.1002\/humu.20748-BIB70","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ajmg.1320520321","article-title":"Genetics of the Costello syndrome","volume":"52","author":"Lurie","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.20748-BIB71","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/humu.10129","article-title":"PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13","volume":"20","author":"Maheshwari","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.20748-BIB72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/humu.20748-BIB73","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1523\/JNEUROSCI.20-07-02504.2000","article-title":"Regulation of long-term potentiation by H-Ras through NMDA receptor phosphorylation","volume":"20","author":"Manabe","year":"2000","journal-title":"J Neurosci"},{"key":"10.1002\/humu.20748-BIB74","first-page":"25","article-title":"Raf proteins and cancer: B-Raf is identified as a mutational target","volume":"1653","author":"Mercer","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/humu.20748-BIB75","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1158\/0008-5472.CAN-05-2211","article-title":"Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts","volume":"65","author":"Mercer","year":"2005","journal-title":"Cancer Res"},{"key":"10.1002\/humu.20748-BIB76","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1038\/sj.onc.1204837","article-title":"Mouse model for lung tumorigenesis through Cre\/lox controlled sporadic activation of the K-Ras oncogene","volume":"20","author":"Meuwissen","year":"2001","journal-title":"Oncogene"},{"key":"10.1002\/humu.20748-BIB77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gde.2006.12.011","article-title":"The role of Shp2 (PTPN11) in cancer","volume":"17","author":"Mohi","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1002\/humu.20748-BIB78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.ejhg.5200935","article-title":"Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome","volume":"11","author":"Musante","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1002\/humu.20748-BIB79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ajmg.a.31658","article-title":"Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: Overlapping clinical manifestations with Costello syndrome","volume":"143","author":"Narumi","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB80","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1002\/humu.20748-BIB81","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ajmg.1320390323","article-title":"The Noonan-CFC controversy","volume":"39","author":"Neri","year":"1991","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.20748-BIB82","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10038-005-0239-7","article-title":"Functional analysis of PTPN11\/SHP-2 mutants identified in Noonan syndrome and childhood leukemia","volume":"50","author":"Niihori","year":"2005","journal-title":"J Hum Genet"},{"key":"10.1002\/humu.20748-BIB83","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB84","first-page":"373","article-title":"Hypertelorism with Turner phenotype","volume":"116","author":"Noonan","year":"1968","journal-title":"A new syndrome with associated congenital heart disease. Am J Dis Child"},{"key":"10.1002\/humu.20748-BIB85","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/nsmb859","article-title":"Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition","volume":"11","author":"Ohren","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1002\/humu.20748-BIB86","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbamcr.2005.06.004","article-title":"Ras signaling from plasma membrane and endomembrane microdomains","volume":"1746","author":"Plowman","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/humu.20748-BIB88","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/ajmg.a.31315","article-title":"Distinguishing Costello versus cardio-facio-cutaneous syndrome: BRAF mutations in patients with a Costello phenotype","volume":"140","author":"Rauen","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB89","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB90","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/300149a0","article-title":"A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene","volume":"300","author":"Reddy","year":"1982","journal-title":"Nature"},{"key":"10.1002\/humu.20748-BIB91","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.1320250303","article-title":"New multiple congenital anomalies\/mental retardation syndrome with cardio-facio-cutaneous involvement-the CFC syndrome","volume":"25","author":"Reynolds","year":"1986","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.20748-BIB92","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB93","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"10.1002\/humu.20748-BIB94","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.40.9.704","article-title":"Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes","volume":"40","author":"Sarkozy","year":"2003","journal-title":"J Med Genet"},{"key":"10.1002\/humu.20748-BIB95","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1136\/jmg.2003.013466","article-title":"Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome","volume":"41","author":"Sarkozy","year":"2004","journal-title":"J Med Genet"},{"key":"10.1002\/humu.20748-BIB96","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/emboj\/16.9.2352","article-title":"Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2","volume":"16","author":"Saxton","year":"1997","journal-title":"EMBO J"},{"key":"10.1002\/humu.20748-BIB97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.ejhg.5200915","article-title":"PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning","volume":"11","author":"Schollen","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1002\/humu.20748-BIB98","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/312071a0","article-title":"Biological properties of human c-Ha-ras1 genes mutated at codon 12","volume":"312","author":"Seeburg","year":"1984","journal-title":"Nature"},{"key":"10.1002\/humu.20748-BIB100","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1074\/jbc.273.11.6233","article-title":"Coordinate regulation of STAT signaling and c-fos expression by the tyrosine phosphatase SHP-2","volume":"273","author":"Servidei","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.20748-BIB101","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1073\/pnas.80.8.2112","article-title":"Three human transforming genes are related to the viral ras oncogenes","volume":"80","author":"Shimizu","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.20748-BIB102","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/humu.20381","article-title":"Paternal bias in parental origin of HRAS mutations in Costello syndrome","volume":"27","author":"Sol-Church","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.20748-BIB103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"Steelman","year":"2004","journal-title":"Leukemia"},{"key":"10.1002\/humu.20748-BIB104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/300143a0","article-title":"Mechanism of activation of a human oncogene","volume":"300","author":"Tabin","year":"1982","journal-title":"Nature"},{"key":"10.1002\/humu.20748-BIB105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00431-005-1679-y","article-title":"A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy","volume":"164","author":"Takahashi","year":"2005","journal-title":"Eur J Pediatr"},{"key":"10.1002\/humu.20748-BIB106","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","article-title":"Small GTP-binding proteins","volume":"81","author":"Takai","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1002\/humu.20748-BIB107","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/300762a0","article-title":"Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change","volume":"300","author":"Taparowsky","year":"1982","journal-title":"Nature"},{"key":"10.1002\/humu.20748-BIB108","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB109","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20748-BIB110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB111","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood-2003-11-3876","article-title":"Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia","volume":"104","author":"Tartaglia","year":"2004","journal-title":"Blood"},{"key":"10.1002\/humu.20748-BIB112","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmg.2005.03.001","article-title":"Germ-line and somatic PTPN11 mutations in human disease","volume":"48","author":"Tartaglia","year":"2005","journal-title":"Eur J Med Genet"},{"key":"10.1002\/humu.20748-BIB113","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","article-title":"Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease","volume":"78","author":"Tartaglia","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.20748-BIB114","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1535-6108(04)00085-6","article-title":"Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects","volume":"5","author":"Tuveson","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1002\/humu.20748-BIB116","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jmg.36.10.799","article-title":"Acute lymphoblastic leukaemia in a patient with cardiofaciocutaneous syndrome","volume":"36","author":"van Den Berg","year":"1999","journal-title":"J Med Genet"},{"key":"10.1002\/humu.20748-BIB117","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1600-0625.2006.00474.x","article-title":"Recurring HRAS mutation G12S in Dutch patients with Costello syndrome","volume":"15","author":"van Steensel","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1002\/humu.20748-BIB118","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"10.1002\/humu.20748-BIB119","first-page":"37","article-title":"Cardio-facio-cutaneous (CFC) syndrome-a distinct entity?","volume":"52","author":"Wieczorek","year":"1997","journal-title":"Report of three patients demonstrating the diagnostic difficulties in delineation of CFC syndrome. Clin Genet"},{"key":"10.1002\/humu.20748-BIB120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ng0797-293","article-title":"Endothelial apoptosis in Braf-deficient mice","volume":"16","author":"Wojnowski","year":"1997","journal-title":"Nat Genet"},{"key":"10.1002\/humu.20748-BIB121","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1210\/jc.2003-032091","article-title":"Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with noonan syndrome","volume":"89","author":"Yoshida","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1002\/humu.20748-BIB122","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajmg.a.30029","article-title":"A 3-bp deletion mutation of PTPN11 in an infant with severe Noonan syndrome including hydrops fetalis and juvenile myelomonocytic leukemia","volume":"128","author":"Yoshida","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB123","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajmg.a.30281","article-title":"Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome","volume":"130","author":"Yoshida","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.20748-BIB124","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/humu.20431","article-title":"Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome","volume":"28","author":"Zampino","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.20748-BIB125","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","article-title":"Genotype-phenotype correlations in Noonan syndrome","volume":"144","author":"Zenker","year":"2004","journal-title":"J Pediatr"},{"key":"10.1002\/humu.20748-BIB126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jmg.2006.046300","article-title":"Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations","volume":"44","author":"Zenker","year":"2007","journal-title":"J Med Genet"},{"key":"10.1002\/humu.20748-BIB127","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejmg.2006.08.003","article-title":"Mild variable Noonan syndrome in a family with a novel PTPN11 mutation","volume":"50","author":"Zenker","year":"2007","journal-title":"Eur J Med Genet"},{"key":"10.1002\/humu.20748-BIB128","doi-asserted-by":"crossref","first-page":"11435","DOI":"10.1016\/S0021-9258(18)82142-1","article-title":"Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2","volume":"268","author":"Zheng","year":"1993","journal-title":"J Biol Chem"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.20748","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/humu.20748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:34:58Z","timestamp":1738197298000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.20748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.20748","relation":{},"ISSN":["1059-7794","1098-1004"],"issn-type":[{"value":"1059-7794","type":"print"},{"value":"1098-1004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}